CA1112571A - Application therapeutique de (s)- et de (rs)-9-(2,3- dihydroxypropyl) - Google Patents

Application therapeutique de (s)- et de (rs)-9-(2,3- dihydroxypropyl)

Info

Publication number
CA1112571A
CA1112571A CA313,756A CA313756A CA1112571A CA 1112571 A CA1112571 A CA 1112571A CA 313756 A CA313756 A CA 313756A CA 1112571 A CA1112571 A CA 1112571A
Authority
CA
Canada
Prior art keywords
adenine
dhpa
dihydroxypropyl
ara
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA313,756A
Other languages
English (en)
Inventor
Erik De Clercq
Antonin Holy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Rega VZW
Czech Academy of Sciences CAS
Original Assignee
Stichting Rega VZW
Czech Academy of Sciences CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega VZW, Czech Academy of Sciences CAS filed Critical Stichting Rega VZW
Application granted granted Critical
Publication of CA1112571A publication Critical patent/CA1112571A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA313,756A 1977-10-20 1978-10-19 Application therapeutique de (s)- et de (rs)-9-(2,3- dihydroxypropyl) Expired CA1112571A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL77.11513 1977-10-20
NL7711513A NL189234C (nl) 1977-10-20 1977-10-20 Therapeutische toepassing van (s)- en (rs)-9-(2,3-dihydroxypropyl)adenine voor de bereiding van een tegen virusziekten werkzaam geneesmiddel, alsmede het gevormde geneesmiddel.

Publications (1)

Publication Number Publication Date
CA1112571A true CA1112571A (fr) 1981-11-17

Family

ID=19829376

Family Applications (1)

Application Number Title Priority Date Filing Date
CA313,756A Expired CA1112571A (fr) 1977-10-20 1978-10-19 Application therapeutique de (s)- et de (rs)-9-(2,3- dihydroxypropyl)

Country Status (4)

Country Link
BE (1) BE871366A (fr)
CA (1) CA1112571A (fr)
FR (1) FR2406446A1 (fr)
NL (1) NL189234C (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836656A (en) * 1972-02-07 1974-09-17 Sandoz Ag Substituted purines as hypolipidemics

Also Published As

Publication number Publication date
FR2406446A1 (fr) 1979-05-18
NL7711513A (nl) 1979-04-24
NL189234C (nl) 1993-02-16
BE871366A (nl) 1979-04-19
FR2406446B1 (fr) 1981-09-11
NL189234B (nl) 1992-09-16

Similar Documents

Publication Publication Date Title
US4724233A (en) Therapeutical application of phosphonylmethoxyalkyl adenines
EP0707481B1 (fr) Analogues de l-2', 3'-didesoxy nucleosides utilises comme agents anti-hepatite b et anti-vih
US4230708A (en) Therapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine for use as antiviral agents
US9351970B2 (en) Anti-viral pyrimidine nucleoside analogues
US5246924A (en) Method for treating hepatitis B virus infections using 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil
US4963533A (en) Therapeutic application of dideoxycytidinene
US4210638A (en) Antiviral composition and method of treating virus diseases
AU623341B2 (en) Antiviral therapy for hepatitis b
US5039667A (en) Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides
US20050261251A1 (en) Antiviral agents and methods of treating viral infections
US5672594A (en) L-erythrosyl nucleosides
HK1000112B (en) Antiviral therapy for hepatitis b using 2',3'-dideoxynucleosides
EP0794781A1 (fr) Medicaments de prevention contre des infections recurrentes par le virus de l'herpes
US5116822A (en) Therapeutic application of dideoxycytidinene
Prince et al. A comparative study of the antitumor and antiviral activity of 1-β-D-arabinofuranosyl-5-fluorocytosine (FCA) and 1-β-D-arabinofuranosylcytosine (CA)
EP0272810A2 (fr) Alkaloide antiviral et antitumoral
IL87646A (en) Preparation for the treatment of hepatitis virus containing 1 -) 2 '- Deoxy - 2' - Fluoro - Beta - B - D - Arabino - Furanozil (- 5 - Orcil
US6001840A (en) Methods of treatment of viral infections using carbocyclic deoxyguanosine analogs
JPS6140206B2 (fr)
JPH04505768A (ja) サイトメガロウイルス感染の予防および治療のための方法および組成物
AU693795C (en) L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV)and anti-HIV agents
HK1061974B (en) Use of compound for manufacturing antiviral agents
GB1588550A (en) Cytidine derivative
AU644412C (en) 6-halo- and 2-amino-6-halo-purine 2',3'-dideoxy nucleosides and their use as antiviral agents
AU644412B2 (en) 6-halo- and 2-amino-6-halo-purine 2',3'-dideoxy nucleosides and their use as antiviral agents

Legal Events

Date Code Title Description
MKEX Expiry